Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 04, 2023

SELL
$22.92 - $33.76 $1,123 - $1,654
-49 Reduced 25.0%
147 $3,000
Q4 2022

Feb 06, 2023

BUY
$25.44 - $59.78 $3,739 - $8,787
147 Added 300.0%
196 $5,000
Q2 2022

Aug 04, 2022

BUY
$28.82 - $77.35 $922 - $2,475
32 Added 188.24%
49 $2,000
Q1 2022

Aug 23, 2022

BUY
$48.25 - $100.49 $193 - $401
4 Added 30.77%
17 $1,000
Q1 2022

Apr 14, 2022

SELL
$48.25 - $100.49 $241 - $502
-5 Reduced 27.78%
13 $1,000
Q4 2021

Feb 14, 2022

BUY
$88.71 - $120.43 $1,153 - $1,565
13 Added 260.0%
18 $2,000
Q3 2021

Nov 10, 2021

BUY
$98.77 - $132.17 $197 - $264
2 Added 66.67%
5 $1,000
Q2 2021

Aug 04, 2021

BUY
$109.77 - $165.68 $219 - $331
2 Added 200.0%
3 $0
Q2 2020

Aug 06, 2020

SELL
$60.49 - $97.5 $181 - $292
-3 Reduced 75.0%
1 $0
Q1 2020

May 12, 2020

BUY
$59.04 - $88.81 $236 - $355
4 New
4 $0

Others Institutions Holding GH

About Guardant Health, Inc.


  • Ticker GH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,220,000
  • Market Cap $4.8B
  • Description
  • Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...
More about GH
Track This Portfolio

Track Glassman Wealth Services Portfolio

Follow Glassman Wealth Services and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Glassman Wealth Services, based on Form 13F filings with the SEC.

News

Stay updated on Glassman Wealth Services with notifications on news.